Stock Markets Analysis & Opinion

Value and Equal Weight ETFs Had a Strong Six Weeks

 

RSP
-0.74%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

EEM
-0.03%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

SPY
-0.34%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

QQQ
-0.06%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

IWM
-0.92%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

VEU
-0.26%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

QQQE
-0.68%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

EMXC
-0.61%

Add to/Remove from Watchlist

Add to Watchlist

Add Position

Position added successfully to:

Please name your holdings portfolio

Type:

BUY
SELL

Date:

 

Amount:

Price

Point Value:


Leverage:

1:1
1:10
1:25
1:50
1:100
1:200
1:400
1:500
1:1000

Commission:


 

Create New Watchlist
Create

Create a new holdings portfolio
Add
Create

+ Add another position
Close

Please excuse the excel spreadsheet, but it’s the easiest way for me to track the data and keep it logical.

Style Box Update

Readers should note the recovery in “value” from 9/30/22. Those YTD returns as of last night had to be re-checked. It was surprising even as crude oil has been relatively flat.

Also surprising was the outperformance of “equal-weight” versus market-cap weight. To hedge the 2001 – 2002 type of market-risk, the RSP was added to client accounts in 2020 and 2021, managing the capital gains within taxable accounts, and by 12/31/21, RSP had made it into the top 10 client positions.

The RSP has done it’s job this year exactly as hoped. now waiting for the breakout in the Russell 2000 (IWM) and biotech has been like Waiting for Godot i.e. much talked about, but never seems to arrive.

Two data points to note:

  • Looking at the middle section of the spreadsheet, i.e. the annualized returns, large-cap growth (the first line) is still out of whack in terms of above-average returns, with the rest of the large-cap value down through small-cap value asset classes. While large-cap growth, which is really dominated by mega-cap stocks, given their influence, large-cap growth could tread water for ’23, even as the other asset classes outperform.
  • Note too the SP 500 (SPY) versus the RSP and the QQQs versus the ares QQQE: while the SPY improved it’s YTD return 8.8% from 9/30 to 10/15, the RSP improved it’s return 11.5%, so the RSP is outperforming in both up and down periods this year. The QQQs improved it’s return 559 bps from 9/30/22 to 11/15, while the QQQE rose 9.38% or 938 bps.

Conclusion

It was long anticipated the “non large-cap growth” asset class would eventually assert itself in terms of market leadership and revert to the mean (so to speak) but in 2022, it just did less worse than the S&P 500 and the mege-cap stock space, rather than positive returns, but that’s all 2022 offered really across US domestic, international and emerging markets. Everything was negative in 2022 (so far) expect energy.

The sudden dollar weakness has driven good volume in some of the EEM ETFs like EMXC and a Vanguard ETF like VEU which is the FTSE All-World Ex-US ETF. The dollar looks broken as this Bespoke chart from yesterday indicates. Pay attention to your favorite Non-US, International and EM funds and ETFs.

USD Index 2022

International has lagged from a return perspective for some time, taking the asset class as a whole.

Take all this with substantial skepticism. Past performance is no guarantee of future results. While the style-box update arrives every 6 weeks, it may contain different emphasis each time. This information and data may not be updated.

Source

Похожие статьи

Добавить комментарий

Ваш адрес email не будет опубликован. Обязательные поля помечены *

Кнопка «Наверх»